
Time is critical in AAV: dampening kidney inflammation prevents damage Why not target effector T cells - leave other T cells alone? Our paper in @NDTSocial defines IL-7Ra as a target doi.org/10.1093/ndt/gfae276 Anti-IL-7Ra Abs are in Phase 2 trials - alopecia @Q32Bio ?an AAV therapy






















